EU countries should align drug pricing policies and resist scattergun responses to pressure on medicine costs, according to a statement from five governments. Belgium, the Netherlands, Luxembourg, Austria and Ireland — members of the Beneluxa initiative — said on Wednesday they favor collaboration on “shared structural challenges” and warn against “uncoordinated individual national responses.” It comes as the U.S. and pharma companies dial up the pressure on EU countries over the prices they

Tag-uri: Austria